Related Experiment Video
Updated: Mar 8, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
[Hypertension and hypercholesterolemia in the Czech population]
Insights
Hypertension and hypercholesterolemia are common in the Czech Republic, with poor control in patients with both conditions. This highlights a need for better management of these cardiovascular risk factors.
Area of Science:
- Cardiology
- Public Health
- Epidemiology
Background:
- Hypertension and hypercholesterolemia are significant, interrelated cardiovascular risk factors.
- Combined, they accelerate atherosclerosis and increase cardiovascular risk.
- Assessing their prevalence and control is crucial for public health.
Purpose of the Study:
- To determine the prevalence of hypertension and hypercholesterolemia in the Czech population.
- To evaluate the control of these risk factors, particularly when co-occurring.
- To inform strategies for cardiovascular risk reduction.
Main Methods:
- A random sample of 2,508 individuals aged 40-64 was studied (2006-2009).
- Hypertension defined by BP levels or medication use.
- Hypercholesterolemia defined by LDL-cholesterol levels or lipid-lowering drug use.
Main Results:
- Prevalence: 52% hypertension, 40% hypercholesterolemia; 30% had both.
- Treatment: 39% used lipid-lowering drugs among those with both conditions.
- Control: Only 42% of treated individuals reached LDL targets; 10% achieved targets for both factors.
Conclusions:
- Control of hypercholesterolemia in hypertensive patients in the Czech Republic is inadequate.
- High prevalence and synergistic risk necessitate considering lipid-lowering drugs for all hypertensive patients.
- Improved management is essential to mitigate cardiovascular risk.
Introduction:
Hypertension and hypercholesterolemia are inter-related ad mutually potentiating cardiovascular risk factors, which, when occurring together, strongly accelerate atherosclerosis and significantly increase cardiovascular risk.The aim of our study was to assess the prevalence and control of both risk factors in the Czech population.
Methods:
A 1 % population random sample aged 40-64 years was examined within the Czech post-MONICA in 2006-2009. Hypertension was defined as systolic blood pressure 140 mm Hg and/or diastolic BP 90 mm Hg or use of antihypertensive medication. Hypercholesterolemia was defined according to cardiovascular risk and LDL-cholesterol levels or use of lipid-lowering drugs.
Results:
In a group of 2 508 persons (51 % of females), hypertension was found in 52 % and hypercholesterolemia in 40 % of examined individuals. Both risk factors occurred together in 30 % of subjects. While lipid-lowering drugs were used by 39 % of individuals with hypertension and hypercholesterolemia, target LDL-cholesterol were achieved by only 42 % of treated individuals. Only a total of 10 % individuals with both hypertension and hypercholesterolemia achieved target levels for both risk factors.
Conclusion:
Treatment and control of hypercholesterolemia in patients with hypertension remains unsatisfactory in the Czech Republic. Taking into account the high prevalence of hypercholesterolemia and the substantial increase in cardiovascular risk, lipid-lowering drugs should be considered in each patient with hypertension.Key words: antihypertensive drugs - Czech post-MONICA - lipid-lowering drugs - SCORE - target values - total cardiovascular risk.
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension I: Introduction
Lipids: Dietary Sources and Requirements

